Grawey Nathaniel A. 4

What Happened
Nathaniel A. Grawey, Chief Commercial Officer of Tenon Medical, was reported as acquiring 68,201 shares on May 1, 2026. The reported transaction is an award/grant (code A) recorded at $0.00 per share (no cash paid). The shares represent Grawey’s indirect pecuniary interest in 276,228 shares issued to SiVantage, Inc. under an asset purchase agreement for achieving a milestone; Grawey holds a 24.69% equity stake in SiVantage and disclaims direct beneficial ownership except to the extent of that pecuniary interest.

Key Details

• Transaction date: 2026-05-01; Form 4 filed: 2026-05-05 (filed timely).
• Transaction type/code: Award/Grant (A); price reported: $0.00; shares attributed to Grawey: 68,201.
• Underlying issuance: Tenon issued 276,228 shares to SiVantage under an August 1, 2025 Asset Purchase Agreement on achievement of a milestone; Grawey’s 24.69% interest yields the 68,201 figure.
• Shares owned after transaction: Not specified on the filing for Grawey (the filing reports an indirect pecuniary interest).
• Footnote: Reporting person disclaims beneficial ownership except for the pecuniary interest via SiVantage.

Context
This was not an open-market purchase or sale by the insider but an indirect award resulting from company shares issued to another entity (SiVantage). Such milestone-based issuances reflect contractual arrangements and don’t directly indicate the insider’s personal trading intent. Because the interest is indirect and the filer disclaims beneficial ownership beyond the pecuniary stake, treat this as reporting of an indirect economic interest rather than a personal buy or sale signal.